Extract from the Register of European Patents

EP About this file: EP3761980

EP3761980 - AMINO ACID COMPOUNDS AND METHODS OF USE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.10.2024
Database last updated on 09.04.2026
FormerThe patent has been granted
Status updated on  27.10.2023
FormerGrant of patent is intended
Status updated on  13.09.2023
FormerRequest for examination was made
Status updated on  07.08.2023
FormerGrant of patent is intended
Status updated on  13.04.2023
FormerRequest for examination was made
Status updated on  11.12.2020
FormerThe international publication has been made
Status updated on  14.09.2019
Most recent event   Tooltip03.10.2024No opposition filed within time limitpublished on 06.11.2024  [2024/45]
Applicant(s)For all designated states
Pliant Therapeutics, Inc.
260 Littlefield Avenue
South San Francisco, CA 94080 / US
[2021/02]
Inventor(s)01 / CHA, Jacob
c/o Pliant Therapeutics, Inc. 260 Littlefield
Avenue South
San Francisco, California 94080 / US
02 / DONG, Chengguo
c/o Pliant Therapeutics, Inc. 260 Littlefield
Avenue South
San Francisco, California 94080 / US
03 / HOM, Timothy
c/o Pliant Therapeutics, Inc. 260 Littlefield
Avenue South
San Francisco, California 94080 / US
04 / JIANG, Lan
c/o Pliant Therapeutics, Inc. 260 Littlefield
Avenue South
San Francisco, California 94080 / US
05 / LEFTHERIS, Katerina
c/o Pliant Therapeutics, Inc. 260 Littlefield
Avenue South
San Francisco, California 94080 / US
06 / LI, Hui
c/o Pliant Therapeutics, Inc. 260 Littlefield
Avenue South
San Francisco, California 94080 / US
07 / MORGANS JR., David J.
c/o Pliant Therapeutics, Inc. 260 Littlefield
Avenue South
San Francisco, California 94080 / US
08 / MUNOZ, Manuel
c/o Pliant Therapeutics, Inc. 260 Littlefield
Avenue South
San Francisco, California 94080 / US
09 / REILLY, Maureen
c/o Pliant Therapeutics, Inc. 260 Littlefield
Avenue South
San Francisco, California 94080 / US
10 / ZHENG, Yajun
c/o Pliant Therapeutics, Inc. 260 Littlefield
Avenue South
San Francisco, California 94080 / US
11 / BAILEY, Christopher
South San Francisco, California 94080 / US
12 / FINKELSTEIN, Darren
South San Francisco, California 94080 / US
 [2023/48]
Former [2021/02]01 / CHA, Jacob
c/o Pliant Therapeutics, Inc. 260 Littlefield
Avenue South
San Francisco, California 94080 / US
02 / DONG, Chengguo
c/o Pliant Therapeutics, Inc. 260 Littlefield
Avenue South
San Francisco, California 94080 / US
03 / HOM, Timothy
c/o Pliant Therapeutics, Inc. 260 Littlefield
Avenue South
San Francisco, California 94080 / US
04 / JIANG, Lan
c/o Pliant Therapeutics, Inc. 260 Littlefield
Avenue South
San Francisco, California 94080 / US
05 / LEFTHERIS, Katerina
c/o Pliant Therapeutics, Inc. 260 Littlefield
Avenue South
San Francisco, California 94080 / US
06 / LI, Hui
c/o Pliant Therapeutics, Inc. 260 Littlefield
Avenue South
San Francisco, California 94080 / US
07 / MORGANS JR., David J.
c/o Pliant Therapeutics, Inc. 260 Littlefield
Avenue South
San Francisco, California 94080 / US
08 / MUNOZ, Manuel
c/o Pliant Therapeutics, Inc. 260 Littlefield
Avenue South
San Francisco, California 94080 / US
09 / REILLY, Maureen
c/o Pliant Therapeutics, Inc. 260 Littlefield
Avenue South
San Francisco, California 94080 / US
10 / ZHENG, Yajun
c/o Pliant Therapeutics, Inc. 260 Littlefield
Avenue South
San Francisco, California 94080 / US
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[2023/48]
Former [2021/02]Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
Application number, filing date19765136.707.03.2019
[2021/02]
WO2019US21243
Priority number, dateUS201862639988P07.03.2018         Original published format: US 201862639988 P
US201862690933P27.06.2018         Original published format: US 201862690933 P
[2021/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019173653
Date:12.09.2019
Language:EN
[2019/37]
Type: A1 Application with search report 
No.:EP3761980
Date:13.01.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 12.09.2019 takes the place of the publication of the European patent application.
[2021/02]
Type: B1 Patent specification 
No.:EP3761980
Date:29.11.2023
Language:EN
[2023/48]
Search report(s)International search report - published on:US12.09.2019
(Supplementary) European search report - dispatched on:EP24.09.2021
ClassificationIPC:A61K31/4375, C07D401/12, A61P43/00, C07D471/04, C07D519/00
[2023/17]
CPC:
C07D471/04 (EP,IL,KR,US); A61K31/4375 (IL,KR); A61K31/506 (KR);
A61P11/00 (KR); A61P43/00 (EP,IL,KR); C07D519/00 (EP,IL,US)
Former IPC [2021/43]A61K31/4375, C07D401/12, A61P43/00
Former IPC [2021/02]A61K31/4375, C07D401/12
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/02]
Extension statesBA07.10.2020
ME07.10.2020
Validation statesKH07.10.2020
MA07.10.2020
MD07.10.2020
TN07.10.2020
TitleGerman:AMINOSÄUREVERBINDUNGEN UND VERFAHREN ZUR VERWENDUNG[2021/02]
English:AMINO ACID COMPOUNDS AND METHODS OF USE[2021/02]
French:COMPOSÉS D'ACIDES AMINÉS ET LEURS PROCÉDÉS D'UTILISATION[2021/02]
Entry into regional phase07.10.2020National basic fee paid 
07.10.2020Search fee paid 
07.10.2020Designation fee(s) paid 
07.10.2020Examination fee paid 
Examination procedure07.10.2020Examination requested  [2021/02]
22.04.2022Amendment by applicant (claims and/or description)
14.04.2023Communication of intention to grant the patent
04.08.2023Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
14.09.2023Communication of intention to grant the patent
25.10.2023Fee for grant paid
25.10.2023Fee for publishing/printing paid
25.10.2023Receipt of the translation of the claim(s)
Divisional application(s)EP23205993.1  / EP4328230
EP24207882.2
Opposition(s)30.08.2024No opposition filed within time limit [2024/45]
Fees paidRenewal fee
12.03.2021Renewal fee patent year 03
14.01.2022Renewal fee patent year 04
12.01.2023Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search  No further relevant documents disclosed
International search[Y] WO2018009501  (UNIV ROCKEFELLER et al.) [Y] 1, 4 * ; entire document *
 [Y] US2002010176  (ASKEW BEN C et al.) [Y] 1, 4 * ; paragraphs [0028]-[0029], [0031]-[0032], [0035], [0153]-[0154], [0391]-[0392] *
by applicantWO2018009501
 US2002010176
   KIM ET AL., PROC. AM. THORAC. SOC., vol. 3, 2006, pages 285 - 292
   LYNCH, D., RADIOLOGY, vol. 221, 2001, pages 583 - 584
   KINDER ET AL., AM. J. RESPIR. CRIT. CARE MED., vol. 176, 2007, pages 691 - 697
   P.G.M. WUTST.W. GREENE: "Greene's Protective Groups in Organic Synthesis", 2006, WILEY-INTERSCIENCE
   "Remington: The Science and Practice of Pharmacy", 2005, LIPPINCOTT WILLIAMS & WILKINS
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.